申请人:Takeda Chemical Industries, Ltd.
公开号:US04775687A1
公开(公告)日:1988-10-04
A thiazolidinedione derivative of the general formula: ##STR1## wherein X is an oxygen or sulfur atom, R.sup.1 and R.sup.2 each independently is hydrogen or a hydrocarbon residue which may optionally be substituted and R.sup.1 and R.sup.2 may jointly, together with the oxazole or thiazole ring, form a condensed ring and A is a lower alkylene group; or a salt thereof, are novel compounds, which exhibit in mammals blood sugar- and lipid-lowering activity, and are of value as a therapeutic agent for diabetes and/or therapeutic agent for hyperlipemia.
一种噻唑烷二酮衍生物的一般式:##STR1## 其中X是氧或硫原子,R.sup.1和R.sup.2各自独立地是氢或一个烃基残基,该烃基残基可以选择性地被取代,且R.sup.1和R.sup.2可以共同,与噁唑或噻唑环一起形成一个紧缩环,A是一个较低的烷基;或其盐,是新的化合物,对于哺乳动物具有降低血糖和血脂的活性,是治疗糖尿病和/或治疗高脂血症的有价值的治疗剂。